Trials / Terminated
TerminatedNCT05471271
IL-2 PET Imaging in Advanced Solid Tumours
An Open Label Pilot Study of [18AlF]-RESCA-IL2 (Interleukin-2 PET Tracer) for Positron Emission Tomography Imaging in Patients Treated With Immune Checkpoint Inhibitors.
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1 (actual)
- Sponsor
- University Medical Center Groningen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an investigator-initiated, single-center, open-label clinical trial designed to evaluate the safety and PK of the PET tracer \[18F\]AlF-RESCA-IL2 in patients prior to and during treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | [18F]AlF-RESCA-IL2 PET scan | Patients will undergo \[18F\]AlF-RESCA-IL2 PET imaging twice; the first \[18F\]AlF-RESCA-IL2 PET scan will be performed at baseline, before starting therapy. The second \[18F\]AlF-RESCA-IL2 PET scan will be performed after 2 weeks of treatment |
Timeline
- Start date
- 2023-10-02
- Primary completion
- 2024-11-01
- Completion
- 2024-11-01
- First posted
- 2022-07-22
- Last updated
- 2025-05-31
Locations
1 site across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05471271. Inclusion in this directory is not an endorsement.